Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
28
Participants
Timeline
Start Date
June 30, 2013
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Conditions
Drug Interactions
Interventions
DRUG
Prednisone
DRUG
VX-509
DRUG
Methylprednisolone
Trial Locations (1)
Unknown
Vertex Investigational Site, Lenexa
All Listed Sponsors
lead
Vertex Pharmaceuticals Incorporated
INDUSTRY
NCT01886209 - Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects | Biotech Hunter | Biotech Hunter